The government has asked the Academy of Medical Sciences to conduct a rapid independent review of the regulation and governance of medical research. This will be chaired by Sir Michael Rawlins in his capacity as a senior fellow.  The review follows concerns that the process of medical research is being jeopardised by a complex legal and regulatory framework. The framework is affecting both:

·        the UK’s competitiveness as a site for industry-funded research (negative impact on the economy); and

·         the speed with which advances in basic science can be turned into benefits for patients (negative impact on improving health).

 In view of the particular problems for clinical trials, the review will have a specific focus in this area.